FDA recall D-66373-001

Sandoz Incorporated · Class III · drug

Product

Hydroxychloroquine Sulfate Tablets, USP, 200 mg, Rx Only, 100 Tablets per bottle, Sandoz Inc., Princeton NJ, 08540, NDC 0781-1407-01.

Reason for recall

Failed Tablet/Capsule Specifications: Sandoz is recalling one lot of Hydroxychloroquine Sulfate Tablets, USP, 200mg, due to illegibility of the logo on some tablets.

Distribution

Nationwide

Key facts

Status
Terminated
Initiation date
2013-09-25
Report date
2013-10-16
Termination date
2014-07-16
Voluntary/Mandated
Voluntary: Firm initiated
Location
Broomfield, CO, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-66373-001